Arecoline Induces ROS Accumulation, Transcription of Proinflammatory Factors, and Expression of KRT6 in Oral Epithelial Cells

Tong-Hong Wang,Yen-Wen Shen,Hsin-Ying Chen,Chih-Chieh Chen,Nan-Chin Lin,Yin-Hwa Shih,Shih-Min Hsia,Kuo-Chou Chiu,Tzong-Ming Shieh

DOI: https://doi.org/10.3390/biomedicines12020412

IF: 4.757

2024-02-10

Biomedicines

Abstract:Areca nut is a major contributor to the high prevalence of oral cancer in Asia. The precise mechanisms by which areca nut stimulates mucosal cells and contributes to the progression of oral cancer urgently require clarification. The current study aimed to assess the effects of arecoline on the normal human gingival epithelium cell line S-G. Cell viability, levels of reactive oxygen species (ROS), protein expression, cellular morphology, and gene expression were evaluated using the MTT test, flow cytometry, Western blot analysis, optical or confocal microscopy, and RT-qPCR. Keratin (KRT6) analysis involved matched normal and cancer tissues from clinical head and neck specimens. The results demonstrated that 12.5 μg/mL of arecoline induced ROS production, tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) mRNA expression in S-G cells. This activation of the MAPK/ERK pathway increased KRT6 expression while limiting cell migration. In head and neck cancer tissues, KRT6B gene expression exceeded that of normal tissues. This study confirms that arecoline induces ROS accumulation in normal cells, leading to the secretion of proinflammatory factors and KRT6 expression. This impedes oral mucosal healing, thereby promoting the progression of oral cancer.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

What problem does this paper attempt to address?

The paper primarily explores the effects of arecoline on oral epithelial cells, particularly how it induces reactive oxygen species (ROS) accumulation, promotes the transcription of pro-inflammatory factors, and the expression of keratin 6 (KRT6). The study found that arecoline can increase ROS production in the normal human gingival epithelial cell line S-G and activate the mRNA expression of pro-inflammatory factors such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). Additionally, by activating the MAPK/ERK signaling pathway, arecoline also increases the expression of KRT6, and the upregulation of KRT6 restricts cell migration.

Specifically, the key findings of the paper include:
1. Arecoline at a low concentration (12.5 μg/mL) can significantly increase ROS levels in S-G cells within a short time (2 to 4 hours).
2. The gene expression of IL-6 is upregulated within 8 hours after arecoline treatment, while the expression of TNF-α significantly increases only after 48 hours.
3. In oral epithelial cells, arecoline can affect cell function by upregulating the expression of KRT6, a process related to the MAPK/ERK signaling pathway.
4. Arecoline has a minor effect on cell proliferation but significantly inhibits cell migration ability.

These findings help explain the mechanism by which betel nut chewing leads to an increased incidence of oral cancer, especially how arecoline, as one of the main components of betel nut, promotes inflammatory responses and the potential cancer development process.